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Abstract
The impact of bacterial morphology on virulence and transmission attributes of pathogens is poorly understood. The
prevalent enteric pathogen Campylobacter jejuni displays a helical shape postulated as important for colonization and host
interactions. However, this had not previously been demonstrated experimentally. C. jejuni is thus a good organism for
exploring the role of factors modulating helical morphology on pathogenesis. We identified an uncharacterized gene,
designated pgp1 (peptidoglycan peptidase 1), in a calcofluor white-based screen to explore cell envelope properties
important for C. jejuni virulence and stress survival. Bioinformatics showed that Pgp1 is conserved primarily in curved and
helical bacteria. Deletion of pgp1 resulted in a striking, rod-shaped morphology, making pgp1 the first C. jejuni gene shown
to be involved in maintenance of C. jejuni cell shape. Pgp1 contributes to key pathogenic and cell envelope phenotypes. In
comparison to wild type, the rod-shaped pgp1 mutant was deficient in chick colonization by over three orders of magnitude
and elicited enhanced secretion of the chemokine IL-8 in epithelial cell infections. Both the pgp1 mutant and a pgp1
overexpressing strain – which similarly produced straight or kinked cells – exhibited biofilm and motility defects. Detailed
peptidoglycan analyses via HPLC and mass spectrometry, as well as Pgp1 enzyme assays, confirmed Pgp1 as a novel
peptidoglycan DL-carboxypeptidase cleaving monomeric tripeptides to dipeptides. Peptidoglycan from the pgp1 mutant
activated the host cell receptor Nod1 to a greater extent than did that of wild type. This work provides the first link between
a C. jejuni gene and morphology, peptidoglycan biosynthesis, and key host- and transmission-related characteristics.
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Introduction
Campylobacter jejuni is a helical, highly motile, Gram-negative e-
Proteobacterium and a prevalent zoonotic organism existing
asymptomatically in the intestinal tract of birds and other animal
species [1–3]. However, ingestion of as few as 500 bacteria can
result in human disease [4]. C. jejuni is the leading cause of
foodborne gastroenteritis in the developed world, causing an acute
self-limiting infection of varying severity that can give rise to severe
complications such as inflammatory bowel disease, reactive
arthritis, and Guillain-Barre´ syndrome (GBS) [5].
C. jejuni lacks many of the frequently identified virulence factors
encoded by other enteric pathogens such as pili, enterotoxins, and
specialized secretion mechanisms [6,7]. Genes affecting funda-
mental aspects of C. jejuni biology in hosts other than humans, such
as stress survival, transmission, and asymptomatic colonization,
also affect virulence in disease models. We found that C. jejuni
strain 81-176 binds calcofluor white (CFW), a compound that
reacts with b1–3 and b1–4 carbohydrate linkages and fluoresces
under long wave UV light [8,9]. The carbohydrate responsible for
CFW reactivity in C. jejuni has not yet been identified, although it
was previously shown not to be one of the well-characterized
surface polysaccharides expressed by C. jejuni: the capsular
polysaccharide, lipooligosaccharide (LOS), N-linked glycoproteins,
or O-linked flagellar glycoproteins [10]. C. jejuni mutants with
altered CFW reactivity can be readily identified in screens. All C.
jejuni CFW hyper- or hyporeactive mutants characterized to date
exhibit changes in pathogenesis, virulence, fundamental, and/or
stress survival phenotypes ([10,11]; E. Frirdich and E. C. Gaynor,
unpublished). For instance, CFW hyper-reactive mutants over-
produce biofilms, while hypo-reactive mutants are biofilm-
defective. Other attributes associated with altered CFW reactivity
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have included defects in colonization, host cell interactions, cell
envelope components, and stress survival. A CFW hypofluorescent
mutant with a lesion in a novel peptidoglycan peptidase gene (pgp1)
serves as the basis of this study.
The helical shape of C. jejuni has long been postulated to be
critical for pathogenic attributes such as the ability to burrow
through the mucosal layer during infection of zoonotic and human
hosts. However, genetic components involved in modulating C.
jejuni morphology had not previously been identified. Morphology
is maintained in most bacteria by the peptidoglycan (PG) layer
[12]. PG is composed of glycan chains consisting of b1–4 linked N-
acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc)
residues that are cross-linked by short peptides. PG synthesis is a
highly regulated process [13,14] taking place at the bacterial inner
membrane, where lipid II precursors are polymerized by
glycosyltransferase and DD-transpeptidase reactions. In addition
to the synthetic enzymes, PG hydrolases are required to cleave
bonds in PG or PG fragments for insertion of nascent PG into the
mature layer, regulation of cell wall growth, cell separation, PG
turnover and recycling, cell lysis, and the release of PG fragments
in host-pathogen interactions [15]. Almost every glycosidic and
amide bond in PG can be cleaved by one or more specific PG
hydrolases, and this redundancy makes it difficult to assign a
specific function to a hydrolase [15,16]. It has been speculated that
murein synthases and hydrolases are part of a multienzyme
complex for PG assembly [16], and several interactions between
PG enzymes have been reported [14].
Campylobacter PG contains meso-diaminopimelic acid (meso-Dap)
in its peptide side chains and is modified by O-acetylation [17,18],
but the detailed muropeptide composition had not previously been
elucidated. Bioinformatic analyses identified 3 putative PG
synthases in C. jejuni: the penicillin-binding proteins (PBPs) PBP1A
(cjj81176_0536), PBP (cjj81176_0550), and PBP2 (cjj81176_0680),
but there are no predicted homologs of low-molecular weight
PBPs such as DD-endo- or carboxypeptidases. C. jejuni does have
homologs of the Csd1 and CcmA endopeptidases and of the
Csd3/HdpA endo/carboxypeptidase discovered recently in Heli-
cobacter pylori [19,20]. Deletion of each of these genes in H. pylori
resulted in curved-rod morphologies with reduced levels of PG
cross-linking [19], but preliminary evidence indicates that these
enzymes may have a different function in C. jejuni (E. Frirdich and
E. C. Gaynor, unpublished).
Here, we report the first C. jejuni gene, pgp1, to be identified with
a role in helical morphology. Structural PG analyses of C. jejuni
wild-type 81-176 and Dpgp1 mutant strains showed striking
alterations in the mutant, with enzyme assays confirming Pgp1
as a novel DL-carboxypeptidase. Furthermore, using the Dpgp1
mutant with a straight morphology, the importance of C. jejuni
helical shape and PG in pathogenesis attributes was examined; we
identified roles in motility, biofilm formation, chick colonization,
and stimulation of host cell proinflammatory mediators Nod1 and
IL-8.
Results
CFW screen for hypofluorescent mutants identifies the C.
jejuni 81-176 gene pgp1
As noted, screening for C. jejuni hypofluorescent mutants was
previously shown to identify genes involved in pathogenesis-related
phenotypes [10]. However, as the Tn7 transposon (Tn) used
previously for mutant library construction was reproducibly found
to have inserted in intergenic regions (M. K. McLennan and E. C.
Gaynor, unpublished), a new random Tn library was generated as
part of this study, using the highly efficient mariner system of in
vitro Tn mutagenesis developed for C. jejuni [21]. The mariner
library was plated onto CFW-containing plates and, from
approximately 10, 000 colonies screened, 400 hypofluorescent
mutants were isolated. Of the Tn insertions mapped, 8 were in
distinct regions of the gene cjj81176_1344 (Figure 1; the CFW
hypofluorescent phenotype is described below). The 1344 gene
was named pgp1 (peptidoglycan peptidase 1) to describe its
function and identification as the first C. jejuni PG peptidase to
be characterized.
The pgp1 gene product is highly conserved in mainly helical and
vibrioid bacteria, primarily within the e- and d-Proteobacteria but
also in a few extremophiles outside the e-Proteobacteria (Table
S1). The H. pylori homolog is described by Sycuro et al. [22]. Pgp1
was annotated as a putative periplasmic protein. However,
bioinformatics using conserved domain searches and the threading
program PHYRE identified an N-terminal signal peptide, a zinc
binding site, and metallocarboxypeptidase catalytic residues and
folds. Pgp1 contains a conserved domain at its N-terminus similar
to that of the M14 family of metallocarboxypeptidases.
Non-polar insertional deletion of pgp1 and
complementation of a pgp1 mutant
To explore functional consequences of loss of Pgp1 function in
C. jejuni, a non-polar pgp1 targeted deletion strain was constructed
(designated Dpgp1 above the gene cluster in Figure 1). To verify
lack of polar effects on the downstream gene, an insertional
mutation was also created in 1343. The D1343 mutant exhibited
wild-type phenotypes for shape, motility, biofilm formation and
CFW reactivity (data not shown; these phenotypes for Dpgp1 are
described below). The level of 1343mRNA was also determined to
be identical in Dpgp1 and in the wild-type strains by semi-
quantitative RT-PCR (data not shown)
The pgp1 gene is located in the middle of a putative operon, and
the location of the pgp1 promoter is unclear from sequence analysis
(Figure 1). Therefore, complementation was first attempted by
expressing the pgp1 gene from the cat promoter of the vector
pRRC (CmR) [23] integrated into an rRNA spacer region of
Author Summary
Bacterial cell shape is dictated by the composition of the
cell envelope component peptidoglycan. Some important
pathogens have a characteristic helical corkscrew mor-
phology that may help them burrow into mucus
overlaying cells to initiate colonization and pathogenicity.
One example is Campylobacter jejuni, the leading cause of
bacterial-induced diarrheal disease in the developed
world. Direct evidence supporting the hypothesis that C.
jejuni shape is related to its pathogenicity traits has not
previously been provided. We identified a gene encoding a
peptidase modifying peptidoglycan that is essential for
maintaining the C. jejuni corkscrew shape. We can now
connect a C. jejuni gene with morphology and peptido-
glycan biosynthesis. Loss of this gene was also found to
affect pathogenic attributes such as chicken colonization,
biofilms, motility, and activation of host inflammatory
mediators. In addition, this is the first study to thoroughly
characterize C. jejuni peptidoglycan structure and to
identify a gene involved in peptidoglycan maintenance.
Our findings highlight an emerging theme in bacterial
pathogenesis research: the connection between bacterial
cell biology and pathogenesis. Finally, our characterization
of C. jejuni cell shape and peptidoglycan provides a
starting point for further work in this area in C. jejuni and
other bacteria with curved and helical morphologies.
Role of pgp1 in C. jejuni Shape and Pathogenesis
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Dpgp1. This construct contained a similar region of pgp1 as shown
for pEF20 in Figure 1 (pEF20 will be described further below) and
did not complement Dpgp1 (data not shown). However, integration
of this same construct into the C. jejuni wild type strain also resulted
in morphological and phenotypic alterations (described below),
suggesting that pgp1 copy number was likely important for
complementation, and that the level of pgp1 expression from the
cat promoter was higher than optimal. To generate a complement-
ing strain expressing pgp1 from its native promoter, increasing
amounts of the region upstream of pgp1 were cloned with pgp1 into
pRRC. These regions were cloned in the opposite direction as cat (to
avoid overexpression from the cat promoter) and integrated into an
rRNA spacer region of Dpgp1. These constructs yielded varying
degrees of complementation, with the pEF35R (Figure 1) construct
complementing nearly all Dpgp1 phenotypes to wild-type levels. The
complemented strain was verified by PCR and designated Dpgp1c.
The pgp1 gene is required for helical morphology, and
Dpgp1 is deficient in CFW reactivity, motility, and biofilm
formation
Since the pgp1 gene product is highly conserved in helical and
vibrioid bacteria, the morphology of the Dpgp1 mutant was
examined. The Dpgp1 mutant displayed a striking change
compared to wild type and had lost the characteristic helical
shape (Figure 2A), adopting a straight morphology (Figure 2B).
Complementation restored the helical shape in approximately
95% of the cells (Figure 2C).
Consistent with the phenotype of the mariner insertion mutants,
the Dpgp1 mutant was hyporeactive to CFW, with wild-type
reactivity restored by complementation (Figure 2D). The Dpgp1
mutant displayed no obvious flagellar structural defects (Figure 2B),
but did exhibit a slight motility defect after incubation for 20 h on
0.4% agar plates, producing halos that were, on average, about
82.5% of wild type (Figure 2E). Motility was restored to wild-type
levels in the complemented strain. Biofilm levels, as assessed by a
crystal violet assay, were approximately 1.2-, 1.5- and 1.6-fold
lower in the Dpgp1 mutant compared to wild type at days 1, 2, and
3, respectively. Biofilm production was partially restored in Dpgp1c
(Figure 2F). No differences between wild type and Dpgp1 were
observed for growth, stress survival, capsule and LOS migration
on acrylamide gels, membrane protein composition, and sensitivity
to antimicrobial compounds (Table S2).
Pgp1 overexpression also affects helical morphology
To assess the effects of pgp1 overexpression, pgp1 was expressed
from either the cat or aphA-3 promoter in pRRC (data not shown)
or pRRK (pEF20 in Figure 1), respectively, and integrated at an
rRNA spacer region of wild-type C. jejuni. Both pRRC and pRRK
derivatives had the same effects on wild type, so only the results for
pEF20 are shown. The pgp1 overexpressing strain displayed an
altered cell shape in approximately 50% of the population,
producing kinked and straight cells among the helical cells
(Figure 3A). This strain also exhibited reduced motility and a
defect in biofilm formation (Figure 3B & C). Reverse transcriptase-
quantitative PCR (RT-qPCR) confirmed that the levels of pgp1
mRNA were 5.1-fold higher in the overexpressing strain than in
wild type. In addition, there was a 1.2-fold increase in pgp1 mRNA
levels in the complementing strain Dpgp1c in comparison to wild
type, which may explain the partial complementation of some
phenotypes. Expression of pgp1 in E. coli had no effect on cell shape
(data not shown).
Peptidoglycan analysis
Muropeptide profile of wild-type C. jejuni 81-176 reveals
numerous stem peptide species. Given the shape phenotype
of the pgp1 mutant strains and the putative peptidase domain of
Pgp1, we hypothesized that Pgp1 cleaves the PG stem peptide.
Since C. jejuni PG had not been fully characterized, we first
analyzed the muropeptide composition of wild type. The HPLC
analysis is shown in Figure 4A, and the structure of individual
muropeptides (Figure 4E) was confirmed by co-elution with known
muropeptides from E. coli [24] and by LTQ-FT-MS/MS (Table 1;
raw data in Tables S3 and S4) [25].
The most abundant muropeptides were the monomers with di-,
tri- and tetrapeptides, as well as dimeric 4-3 cross-linked
TetraTetra and TetraTri species. Only one very minor peak with
a pentapeptide side chain was detected in C. jejuni, a TetraPenta
dimer with a Gly residue at position 5, as opposed to the more
common D-Ala. Muropeptides with 3-3 crosslinks or Lys-Arg
residues indicating bound lipoprotein were not detected and thus
are either not present or present in very small amounts. The
degree of cross-linking at 29.5% is consistent with the value of
30% published previously [17]. The average glycan chain length
determined by the fraction of 1,6-anhydromuramic acid contain-
ing muropeptides from chain ends was 14.7 dissacharide units.
The PG glycan backbone of two different strains of C. jejuni was
reported to be modified with O-acetyl groups at levels of 55.7%
and 62% relative to MurNAc content [18]. The fact that we
observed lower levels of O-acetylation in our analyses (5.7%) is
likely due to the loss of most of the labile O-acetyl groups in the
standard alkaline muropeptide reduction procedure applied in this
study.
Figure 1. C. jejuni 81-176 pgp1 gene locus. Dpgp1 was constructed by deleting 880 bp of pgp1and inserting the non-polar aphA-3 KmR cassette;
the approximate location of this insertion is shown above the gene cluster and is denoted by the Dpgp1 strain designation. The regions cloned into
the integrative vectors pRRC (pEF35R; CmR) or pRRK (pEF20; KmR) used for complementation and overexpression, respectively, are shown below the
gene cluster. An R after the plasmid name indicates that the region is cloned in the opposite direction as the antibiotic resistance cassette promoter.
doi:10.1371/journal.ppat.1002602.g001
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Loss of pgp1 and Pgp1 overexpression result in altered PG
muropeptide profiles. PG from the Dpgp1 mutant, comple-
ment (Dpgp1c), and pgp1 overexpression (81-176+pgp1) strains was
isolated, and the muropeptide profiles were analyzed by HPLC as
above (Figure 4A–D, Tables 1 and S4). The Dpgp1mutant exhibited
a number of changes from wild type, most significantly a striking
increase in tripeptides and reduced dipeptides and tetrapeptides.
The overexpression strain (81-176+pgp1) exhibited the opposite
profile from Dpgp1, with a decrease in total tripeptides, an increase
in total dipeptides, and to a lesser extent, an increase in tetrapeptides
and Gly-containing pentapeptides. Complementation restored
many of the changes in Dpgp1 to near-wild-type levels; however,
pgp1 may be modestly overexpressed in Dpgp1c based on some
similarities to the 81-176+pgp1 profile. The overall degree of cross-
linking did not vary significantly between the different strains.
Together with sequence analysis (see above), the PG data suggests
Pgp1 functions as a DL-carboxypeptidase, hydrolyzing the D-Glu-
meso-Dap bond in tripeptides to form dipeptides. Loss of most O-
acetyl groups in the PG preparation techniques used in this study
precluded exact quantification of this PG glycan backbone
modification in the Dpgp1 mutant. As PG O-acetylation confers
resistance to lysozyme [26,27], it would be expected that if Pgp1
affects O-acetylation, the Dpgp1 mutant would display a change in
lysozyme sensitivity. In the presence of the metal chelator EDTA to
permeabilize the outer membrane, no difference in MIC for
lysozyme was observed between wild type and Dpgp1 strains (Table
S2). Biochemical analyses (described below) confirming Pgp1 as a
DL-carboxypeptidase cleaving the PG stem peptide further
suggested no functional involvement of Pgp1 in O-acetylation,
thus additional experiments to assess this were not pursued.
Pgp1 is a metal-dependent DL-carboxypeptidase cleaving
monomeric disaccharide tripeptides to dipeptides. Pgp1
protein was expressed and purified from E. coli (Figure 5A) and
incubated with purifiedDpgp1 PG to assess the biochemical function of
the protein. The resultant PG was analyzed as above, and the
muropeptide profiles were compared to that of Dpgp1 (Figure 5B–D,
Tables 1 and S4). In the presence of ZnCl2, the addition of Pgp1
resulted in a striking increase in monomeric dipeptides with a
concomitant decrease in monomeric tripeptides, characteristic of a
metal-dependent DL-carboxypeptidase (Figure 5C; Table 1). This
activity was eliminated in the absence of ZnCl2 with added EDTA,
establishing the dependence of Pgp1 on divalent ions (Figure 5D). This
confirmed Pgp1 as a metal-dependent DL-carboxypeptidase cleaving
monomeric disaccharide tripeptides to dipeptides (Figure 5E).
The effect of pgp1 on host-related phenotypes
Dpgp1 is defective for in vivo chick colonization. A C.
jejuni chick colonization model was used to determine the role of
Figure 2. A pgp1 mutant has a straight morphology and defects in CFW reactivity, motility, and biofilms. Negatively stained TEM
images of A, the helical C. jejuni 81-176 strain; B, the straight Dpgp1 strain with intact flagella; and C, the complemented strain Dpgp1c with restored
helical morphology in 95% of the population. D, Dpgp1 is hypofluorescent after 48 h of growth on plates containing 0.002% CFW which is restored
by complementation. E, Dpgp1exhibits a slight motility defect, as assayed by measuring halo diameters in soft agar plates. Standard error of the
mean was calculated from 12 measurements. F, Dpgp1 is defective for biofilm formation, partially complemented in Dpgp1c. Biofilm formation was
assessed by crystal violet staining of standing cultures in borosilicate tubes and quantification of dissolved crystal violet at 570 nm. Standard errors of
the mean were calculated from triplicate cultures and are representative of three independent experiments. The asterisk (*) indicates a statistically
significant difference using the unpaired Student’s t-test, with * or ** indicating p,0.05 or p,0.01, respectively. Numerous other phenotypes showed
no difference from wild type (Table S2).
doi:10.1371/journal.ppat.1002602.g002
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pgp1 in vivo. One-day old chicks were infected orally with a dose of
104 C. jejuni wild-type 81-76, Dpgp1, or Dpgp1c, and cecal contents
were assessed for C. jejuni after 6 days. The Dpgp1 mutant exhibited
a statistically significant (p 0.0009) 2.9-log decrease in average
levels of colonization compared to wild type (Figure 6A).
Complementation restored colonization levels to within 0.5-log
of wild type (Figure 6A). As a control to explore whether the slight
motility defect of Dpgp1 may be responsible for the reduction in
chick colonization, we also infected chicks with a DcarB mutant
[10]. carB encodes carbamoylphosphate synthase and is directly
downstream of an intergenic Tn7 insertion in a CFW
hypofluorescent mutant (dim13) isolated in a previous screen
[10]. A DcarB mutant had wild-type helical morphology, but
displayed a slight motility defect of approximately 86.0% that of
wild-type (Figure S1) and a hypofluorescent phenotype on CFW
similar to Dpgp1 [10]. However, unlike Dpgp1, the DcarB mutant
showed no statistically significant change in chick colonization
(Figure S1).
In vitro invasion and intracellular survival in epithelial
and macrophage cell lines are not dramatically affected in
Dpgp1. The human epithelial cell lines T84, Caco-2 and
INT407, and the murine RAW 264.7 and human Thp-1
macrophage cell lines were used in gentamicin protection assays
to examine the role of pgp1 in C. jejuni invasion and intracellular
(IC) survival in vitro. No defects in invasion were observed for any
cell line (2 h post gentamicin treatment). In epithelial cells, Dpgp1
exhibited a 0.5 log increase in IC survival compared to wild type
7 h post gentamicin treatment (shown for Caco-2 cells in Figure
S2). This was also seen at 5 h and 9 h (data not shown), but not at
21 h post gentamicin treatment. No differences in IC survival were
observed in either macrophage cell line tested (data not shown).
Because of the modest motility defect of Dpgp1 in soft agar, we
also wished to assess whether attachment and invasion might be
altered in a tissue culture medium of higher viscosity. MEM
supplemented with carboxymethylcellulose (CMC) was previously
used to demonstrate increased host cell attachment and invasion
for some strains of C. jejuni in a higher viscosity medium [28].
INT407 cells were infected with C. jejuni 81-176 and Dpgp1 in
MEM containing CMC. No significant difference in invasion was
seen after 1 h or 3 h with the addition of 0.6%, 1% or 2% CMC
(Figure S2). Furthermore, CMC addition decreased the total levels
of invaded bacteria for both the wild type and mutant strains.
PG changes in C. jejuni Dpgp1 result in an altered
epithelial cell Nod1 response. PG is recognized by Nod-like
receptors of the innate immune system. To test whether the PG
changes resulting from a pgp1 mutation altered Nod receptor
stimulation, we measured expression of a NF-kB lgk luciferase
reporter transfected in human embryonic kidney HEK293T cells
along with either the human (h)Nod1, mouse (m)Nod1, or human
(h)Nod2 receptor (Figure 6B–D). We found that PG from the
Dpgp1 mutant produced a statistically significant increase in
mNod1 activation compared to wild type. In contrast, Dpgp1
mutant PG did not produce a statistically significant change in
stimulation of hNod1, despite a modest increase from wild type. C.
Figure 3. Overexpression of pgp1 in the wild-type strain has cell straightening effects and causes reduced motility and a biofilm
formation defect. The pgp1 gene was overexpressed by integration of pgp1 expressed from the aphA-3 promoter from pEF20 into C. jejuni 81-176.
A, negatively stained TEM images of C. jejuni 81-176 overexpressing pgp1. B, motility assayed by measuring halo diameter of growth in soft agar
plates. Error bars were calculated from 12 measurements. C, biofilm formation was assessed by crystal violet staining of standing cultures in
borosilicate tubes and quantification of dissolved crystal violet at 570 nm. Standard errors of the mean were calculated from triplicate readings and
are representative of three independent experiments. The asterisk (*) indicates a statistically significant difference using the unpaired Student’s t-test,
with *, **, or *** indicating p,0.05, p,0.01 or p,0.001, respectively.
doi:10.1371/journal.ppat.1002602.g003
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Figure 4. HPLC elution profile of C. jejuni muropeptides and proposed muropeptide structures. Purified PG was digested with cellosyl
and the resulting muropeptides were reduced with sodium borohydride and separated on a Prontosil 120-3-C18 AQ reverse-phase column. HPLC
profiles are shown for A, C. jejuni wild-type 81-176; B, Dpgp1; C, the complement Dpgp1c; D, the pgp1 overexpressing strain, 81-176+pgp1. Peak
numbers correspond to the main muropeptide peak fractions of C. jejuni 81-176 analyzed by LTQ-FT-MS (Table S3) to determine the structures shown
in E. G, N-acetylglucosamine; M, reduced N-acetylmuramic acid; L-Ala, L-alanine; D-iGlu, D-isoglutamic acid; D-Glu, D-glutamic acid; meso-DAP, meso-
Role of pgp1 in C. jejuni Shape and Pathogenesis
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jejuni wild type PG stimulated Nod2; however, there was no
statistically significant difference in activation levels between the
wild type and Dpgp1 mutant PG.
Secretion of interleukin-8 (IL-8) is increased by exposure
of epithelial cells to Dpgp1. It was previously shown that
epithelial cells produce IL-8 in response to C. jejuni infection [29].
To examine the effect of the Dpgp1 mutation on IL-8 secretion, the
INT407 human epithelial cell line was infected with C. jejuni wild
type and Dpgp1 strains, and the levels of IL-8 secreted into the
supernatant were measured by ELISA (Figure 6E). The data
shown in Figure 6E are representative of three separate
experiments. IL-8 secretion from cells exposed to Dpgp1 after 8 h
was reproducibly higher than wild type, and in some experiments
was statistically significant (not shown). After 24 h, release of IL-8
in response to Dpgp1 was 1.5-fold higher than wild type and
statistically significant in every experimental trial.
Discussion
Bacterial cell shape programs and their impact on biology are
becoming increasingly well-characterized for model organisms like
E. coli and Caulobacter crescentus [30,31]. However, studies linking
bacterial shape and pathogenesis are in their infancy. This is the
first report to address the morphogenesis program of the prevalent
foodborne pathogen C. jejuni. Furthermore, apart from three
annotated uncharacterized PBPs, no other C. jejuni PG-modifying
enzymes have been identified. This is in spite of the fact that, as
our study demonstrates, C. jejuni produces numerous muropeptide
diaminopimelic acid; Gly. Glycine; Ac, O-acetyl groups at the C-6 hydroxyl group of MurNAc; Anh, 1,6-anhydro group at MurNAc. The asterisk (*)
indicates that it is not known on which MurNAc residue the modification occurs.
doi:10.1371/journal.ppat.1002602.g004
Table 1. Summary of muropeptide composition of C. jejuni wild-type 81-176, Dpgp1 mutant, Dpgp1 complement (Dpgp1c), and
pgp1 overexpression (81-176+pgp1) strains, and the resultant Dpgp1 PG profiles of Pgp1 activity assays consisting of Dpgp1 PG
incubated without enzyme, with Pgp1 in the presence of ZnCl2, and with Pgp1 without ZnCl2 but with EDTA.
% Peak area1
Muropeptide species In C. jejuni strains Following incubation of Dpgp1 PG
81-176 Dpgp1 Dpgp1c
81-176 +
pgp1
Dpgp1 PG -
Pgp1
Dpgp1 PG +
Pgp1+ ZnCl2
Dpgp1 PG + Pgp1
+ EDTA
Monomers (Total) 43.3 43.4 43.1 42.1 41.1 45.4 52.4
Di 14.5 5.9* 20.6* 18.4* 5.6 31.9* 5.9
Tri 10.5 34.4* 3.3* 2.3* 32.6 2.0* 33.9
Tetra 18.4 3.1* 19.2 21.5 2.9 11.5* 12.6*
Acetylated2 3.3 5.1 4.2 4.0 0.7 2.2 2.1
Anhydro 1.0 2.0* 3.0*
Dimers (Total) 49.7 52.5 49.3 50.0 52.4 49.0 42.3
Tetra Tri 14.7 37.0* 6.8* 3.7* 37.9 36.5 31.9
Tetra Tetra 33.5 14.7* 40.8* 44.4* 13.5 11.5 9.6
Tetra PentaGly5 1.5 0.7* 1.6 1.9* 0.9 0.9 0.8
Anhydro 10.8 11.7 11.3 10.5 12.7 7.8* 5.8*
Acetylated2 4.8 6.8 3.8 5.5 0.2 2.8 1.6
Trimers (total) 6.9 4.2* 7.6 7.9 6.5 5.6 5.3
Tetra Tetra Tri 0.8 1.9* 0.6* 0.3* 3.0 2.6 2.4
Tetra Tetra Tetra 6.1 2.3* 7.0 7.6* 3.6 3.0 2.9
Dipeptides (Total) 14.5 5.9* 20.6* 18.4* 5.6 31.9* 5.9
Tripeptides (Total) 18.1 53.6* 6.9* 4.2* 52.5 21.2* 50.7
Tetrapeptides (Total) 66.7 40.2* 71.6 76.5 41.4 46.5 43.0
Pentapeptides (Total) 0.7 0.4* 0.8 1.0* 0.5 0.5 0.4
Acetylated (Total)2 5.7 8.5 6.1 6.7 0.8 3.6 2.9
Anhydro chain ends (Total) 6.8 6.4 7.2 6.9 7.2 10.7* 10.1
Average chain length 14.7 15.7 13.9 14.5 13.9 9.3* 9.9
Degree of cross-linkage 29.5 29.0 29.7 30.2 30.5 28.2 24.7
% Peptides in cross-links 56.7 56.6 56.9 57.9 58.9 54.6 47.6
1Numbers represent the percent area of each muropeptide from Table S4 calculated to give a total of 100%. Values indicated with an asterisk (*) represent an equal to
or greater than 20% difference in comparison to wild-type 81-176 or Dpgp1 PG to which no enzyme was added; bolded asterisked values (*) indicate a greater than 30%
change.
2Values for the percentage of O-acetylated species do not represent the true level of PG O-acetylation in these strains, as most O-acetyl groups are lost in the standard
alkaline muropeptide reduction procedure used in this study.
doi:10.1371/journal.ppat.1002602.t001
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species indicative of additional unidentified and potentially novel
PG hydrolases.
Our identification and characterization of pgp1 provides the first
link between cell shape and PG in C. jejuni. Pgp1 is conserved
primarily in bacteria with curvature (Table S1). Although
functions have not yet been ascribed for other putative shape-
related proteins in C. jejuni, it is of note that helical e- and d-
proteobacteria also typically contain the elongase and cytoskeletal
components MreB, MreC, and RodA, but not MreD or RodZ. As
such, unique PG and morphogenesis programs are likely to be
identified both within and among these organisms, which in turn
will lend new insight into their biology and pathogenesis.
Enzyme assays demonstrated that Pgp1 is a metal-dependent DL-
carboxypeptidase cleaving monomeric disaccharide tripeptides to
disaccharide dipeptides. This is consistent with Pgp1 harboring an
N-terminal M14 metallocarboxypeptidase domain present in two
other PG dipeptidyl peptidases, E. coli MpaA and Bacillus sphaericus
ENP1, which cleave tri- and tetrapeptides to dipeptides [32–35].
This also correlates with the reduction in dipeptides and increase in
tripeptides in Dpgp1 PG. Decreased tetrapeptides in Dpgp1 may be
an indirect consequence of the increased level of tripeptides
affecting activity of DD-carboxypeptidases, or an indirect effect
on other PG hydrolases via disruption of a putative enzyme
complex. Efforts to identify Pgp1 binding partners that would
support the latter hypothesis are underway. Our muropeptide
analysis of C. jejuni 81-176 wild-type PG also revealed a muropeptide
composition expected for a Gram-negative species, with several
interesting differences from the related helical organism H. pylori
[19,36] and the rod-shaped E. coli [14,24] (Table S5). For instance,
unlike H. pylori, C. jejuni contains very low levels of pentapeptides,
suggesting high DD-carboxypeptidase activity. C. jejuni PG also has
a higher level of cross-linking than either other species, and a
relatively short average glycan chain length.
With pgp1 being the first C. jejuni gene directly linked with helical
morphology, it allowed for the first direct comparison between a
helical wild type strain and an isogenic targeted rod-shaped
mutant in critical aspects of C. jejuni pathogenesis and survival. The
modest motility defect of the rod-shaped Dpgp1mutant may in part
account for the modest biofilm defect [37–39]. Further corrobo-
rating the pgp1-biofilm connection are our observations that pgp1 is
up-regulated in the hyperbiofilm-forming DcprS strain (S. Svensson
and E. C. Gaynor, unpublished) and that Dpgp1 is hyporeactive to
CFW [10]; the latter observation in turn continues to support a
link between C. jejuni CFW reactivity and key biological and
pathogenic processes. Isolated PG, which has a b1–4 disaccharide
backbone, binds to CFW (E. Frirdich and E. C. Gaynor,
unpublished), suggesting that changes in PG architecture in Dpgp1
may account for decreased CFW reactivity. However, as PG
isolated from both wild type and mutant strains bound CFW
equally well, a related explanation is that PG alterations affect the
accessibility of CFW to binding sites on periplasmic PG molecules.
The Dpgp1 mutant also allowed us to explore roles for shape and
PG composition on host interactions. Surprisingly, the Dpgp1
mutant was not defective for host cell attachment or invasion in
vitro and even displayed a slight increase in short-term intracellular
survival. Increasing the viscosity of the media did not affect the
ability of the mutant to invade epithelial cells (Figure S2). It is of
note that although attachment and invasion to host cells increased
for some C. jejuni strains in higher viscosity medium [28], this was
not the case for our highly invasive wild-type strain 81-176,
suggesting varying invasion programs among different C. jejuni
strains.
Intracellular C. jejuni was previously shown to induce host
epithelial cell inflammatory responses via activation of the
cytoplasmic Nod receptors [40,41], which recognize distinct PG
muropeptide molecules. The minimal molecule recognized by
Figure 5. Pgp1 has metal-dependent DL-carboxypeptidase activity on Dpgp1 PG, cleaving monomeric tripeptide disaccharides to
dipeptides. A, SDS-PAGE analysis of affinity purified Pgp1 with a predicted molecular weight of 67.9 kDa, indicated by an arrow. HPLC
chromatograms of B, purified Dpgp1 PG; C, Dpgp1 PG incubated with purified Pgp1 and ZnCl2; and D, Dpgp1 PG with purified Pgp1 and EDTA. Peaks
corresponding to monomeric disaccharide dipeptides and tripeptides are indicated. E, a schematic diagram of the Pgp1 cleavage site indicated with
an arrow. G, N-acetylglucosamine; M, reduced N-acetylmuramic acid; L-Ala, L-alanine; D-iGlu, D-isoglutamic acid; meso-DAP, meso-diaminopimelic
acid.
doi:10.1371/journal.ppat.1002602.g005
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hNod2 is muramyl dipeptide (MDP), a structure common to PG
from both Gram-negative and Gram–positive organisms [42].
hNod1 and mNod1 recognize DAP-containing muropeptides
restricted to Gram-negative organisms. hNod1 exhibits a prefer-
ence for tripeptides and mNod1 for tetrapeptides; however
mNod1 also, to a lesser degree, recognizes DAP-containing
tripeptides ([43]; J. Lee and S. Girardin, unpublished). Luciferase
assays are a sensitive method to probe the capacity of a PG
preparation to trigger Nod1 or Nod2 and provide complementary
information to PG compositional data by HPLC and MS analyses.
Using these assays, only mNod1 exhibited a statistically significant
difference in activation by Dpgp1 PG compared to wild type. It is
possible that C. jejuni modifies its PG in a manner that affects Nod
signaling, as modifications of the PG backbone have been shown
to affect how PG fragments are sensed by host cell receptors [44].
This poses an interesting question for future work. Our data also
indicate that wild-type PG can activate hNod2, consistent with
findings by Al-Sayeqh et al. (2010) who also showed NF-kB
activation in HEK293T cells transfected with Nod2 and infected
with live C. jejuni. While Zilbauer et al. (2007) did not observe C.
jejuni activation of Nod2, this may reflect differences between cell
lines used in these assays, and/or differences in reporter sensitivity.
Nod activation is an important aspect of innate immunity
against C. jejuni [40,41]; however, the mechanism by which C. jejuni
Figure 6. The role of cell shape and PG composition on host related phenotypes. A, Dpgp1 is defective for chick colonization. Each point
represents the log CFU/g cecal contents of an individual chick 6 days following infection with 104 CFUs of the indicated C. jejuni strains. The
geometric mean is denoted by a black bar. B–D, to assay the ability of C. jejuni wild type and Dpgp1 PG to activate Nod proteins, human embryonic
kidney cells (HEK293T) were co-transfected with either C. jejuni 81-176 or Dpgp1 PG at 0.1 mg/mL, vectors for a NF-kB luciferase reporter, and either
human Nod1 (B, hNod1), mouse Nod1 (C, mNod1) or human Nod2 (D, hNod2). Nod activation was determined by measuring the activity of the NF-
kB luciferase reporter in comparison to the non-stimulated (NS) negative control. Positive controls used were TriDAP, FK565, and MDP. Data represent
the mean6 SEM of three independent experiments. E, Deletion of pgp1 increases IL-8 secretion in the INT407 epithelial cell line. Quantification of IL-
8 levels was performed by ELISA. Data represent the mean 6 SEM of three independent experiments. The asterisk (*) indicates a statistically
significant difference using the unpaired Student’s t-test, with * or *** indicating p,0.05 or p,0.001, respectively.
doi:10.1371/journal.ppat.1002602.g006
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PG fragments may reach the cytosol to activate Nod1 and/or
Nod2 has not been elucidated. C. jejuni can be internalized into
intestinal epithelial cells, surviving within an intracellular mem-
brane-bound compartment known as the C. jejuni-containing
vacuole (CCV) [45]. An oligopeptide transporter expressed in
the early endosome has been implicated in the transport of Nod
ligands from the endosome to the cytoplasm in HEK293T cells
[46]; a similar system could allow cytoplasmic delivery of PG
fragments from C. jejuni in the CCV. Another possibility is that
during growth in the extracellular environment C. jejuni may shed
part of its PG, as shown for other bacteria [44,47,48]; released
Nod1 and Nod2-stimulatory molecules could then be transported
to the cytoplasm by oligopeptide transporters or taken up by
phagocytosis or clathrin-dependent endocytosis and transported to
the cytosol to activate Nods [44,49–51]. Bacterial outer membrane
vesicles may also play a role in delivering C. jejuni Nod ligands to
the cytoplasm [52].
Production of IL-8 and other proinflammatory mediators by
intestinal epithelial cells infected with C. jejuni is thought to be key
to the development of diarrhea and clearance of infection.
Zilbauer et al. (2007) suggested that C. jejuni Nod1 activation is
the primary signaling event required for IL-8 expression in Caco-2
intestinal epithelial cells. However, other work indicates that C.
jejuni-induced IL-8 secretion can be triggered by other pathways in
addition to the activation of Nod1, such as through Toll-like
receptors (TLRs) and a pathway independent of Nods and TLRs
that has yet to be identified [40,53–58]. Thus while the increase in
IL-8 secretion in response to Dpgp1 may be due to the modest
increase in hNod1 activation observed in our luciferase assays, it
cannot be ruled out that deletion of pgp1 leads to a change in
another, as-yet unidentified factor stimulating IL-8 expression.
Future work is planned to address these hypotheses.
Our colonization data are in agreement with the longstanding
hypothesis that the corkscrew morphology of C. jejuni is critical for
burrowing into the mucus layer; however, the impact of shape and
PG on colonization may be multifactorial. For instance, motility is
a key factor in colonization [59–64], thus the Dpgp1 colonization
defect may in part be due to its decreased motility. However, a
DcarB mutant with a similar motility defect was not deficient for
chick colonization (Figure S1). When the strongly colonizing C.
jejuni strain 305/94 was re-isolated from chickens, it displayed a
more pronounced motility defect than Dpgp1 despite having
normal flagella, and had lost its helical shape, exhibiting a similar
straight morphology as Dpgp1 [65]. It is intriguing to hypothesize
that not only shape, but also the underlying structure of the PG
may play an important role in colonization. We have found that a
straight phenotype can arise from various changes in muropep-
tides based on preliminary analysis of other straight mutants
identified in our laboratory (E. Frirdich, J. Vermeulen, and E. C.
Gaynor, unpublished). PG changes or changes resulting from the
loss of pgp1 could cause as-yet uncharacterized alterations to the
cell surface affecting the ability of C. jejuni to survive in the chicken
cecum, or affect host cell interactions and stimulation of innate
immune receptors. Our understanding of the chicken innate
immune system and how it responds to C. jejuni is in its infancy.
The chicken genome encodes Nod1 but not Nod2, although
chickens possess an ortholog of the NLRP3/NALP3 Nod-like
receptor that is similar to Nod2 and also binds MDP [66,67].
NLRP3 may substitute for Nod2 in chickens. Further insight into
mechanisms by which C. jejuni survives commensally in the chicken
cecum requires additional studies of these and other innate
immune system factors.
Identification and characterization of pgp1 provides a critical
first step in understanding how shape and PG modifications
impact C. jejuni pathogenesis. However, the shape program itself in
C. jejuni is likely to be somewhat complicated. For instance, to the
best of our knowledge, Pgp1 is the only PG modifying enzyme to
date where overexpression causes cell straightening, indicating that
the precise dose of Pgp1 is important for maintenance of
morphology. One interpretation of this finding is that the proper
ratio of monomeric tripeptides to dipeptides, which is disrupted in
both the Dpgp1 mutant and pgp1-overexpressing strains, may be
required for proper shape determination. It is also possible that
excess Pgp1 could, as suggested for loss of Pgp1 above, indirectly
affect other PG hydrolases by disrupting the stoichiometry of a
putative PG biosynthetic/modification complex. Additional com-
plexities in the shape program are evidenced by reports of straight
Campylobacter strains in the literature for which the morphological
change has not yet been attributed to mutations in specific gene
product(s). For instance, some C. jejuni flagellar mutants appeared
to have a straight morphology [68–70]; however, other mutants
with lesions in the same flagellar genes remained helical ([71,72];
E. Frirdich and E. C. Gaynor, unpublished). Two reports also
cited that passage through the chicken gut or chick embryos
resulted in straight C. jejuni isolates [65,73]. Conversely, laboratory
passage has led to the isolation of poorly colonizing rod-shaped C.
jejuni and C. coli strains [74,75]. In the 11168-GS (straight) and
11168-O (helical) strains of the 2004 study, sequence and
expression levels of pgp1 were found to be identical (E. Frirdich
and E. C. Gaynor, unpublished). Collectively, this suggests not
only that genes other than pgp1 affecting morphology remain to be
discovered, but also that mechanisms such as phase variation and/
or epigenetics may be involved.
The pgp1 homolog in H. pylori (named csd4) was identified in a
screen for cell shape mutants and is described by Sycuro et al.
[22]. Morphology, PG profile, and enzymatic activity indicate
conserved functions for the gene products in both organisms.
While some enzymes and their effects on morphology are
conserved between these related helical bacteria, there are also
likely to be differences in the overall PG remodeling and shape
determining programs, particularly given their very different wild-
type muropeptide profiles.
The Dpgp1 mutant will be a valuable tool to continue to study
the effects of the loss of C. jejuni helical shape on its biology and
pathogenesis. So far, pgp1 has been found to be important for all
aspects of the C. jejuni life cycle. As this study represents the first
identification of a gene involved in C. jejuni helical shape and of a
role for PG in shape determination, it will also provide the basis for
work characterizing additional enzymes involved in C. jejuni PG
biosynthesis and shape determination. These studies have now
been made easier by the availability of PG structural data for the
wild-type C. jejuni strain 81-176 published as part of this work.
Future detailed biochemical and structural studies on Pgp1 will
also provide interesting insight into the function of this key protein
in C. jejuni physiology.
Materials and Methods
Ethics statement
Animal experiments were carried out in strict accordance with
the University of Michigan Committee on Use and Care of
Animals (UCUCA). Animal infection and euthanasia protocols
were approved by the University of Michigan UCUCA and
assigned approval number 10462. Oral gavage was carried out
under humane guidelines using an approved protocol judged not
to cause distress or harm to the animals. Euthanasia was carried
out under humane guidelines using a lethal dose of isofluorane. All
animal use procedures are in compliance with University
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guidelines, State and Federal regulations, and the standards of the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals. The University of Michigan Animal Welfare
Assurance Number on file with the NIH Office of Laboratory
Animal Welfare (OLAW) is A3114-01, and the University is fully
accredited by the Association for the Assessment and Accredita-
tion of Laboratory Animal Care International (AAALAC, Intl.).
Bacterial strains and growth conditions
Bacterial strains and plasmids used in this study and their
construction are described in Text S1. C. jejuni strains were grown
at 38uC in Mueller-Hinton (MH; Oxoid) broth or 8.5% (w/v) agar
supplemented with vancomycin (10 mg/mL) and trimethoprim
(5 mg/mL) (unless otherwise indicated) under microaerobic/
capnophilic conditions (6% O2, 12% CO2) in a Sanyo tri-gas
incubator for plates or using the Oxoid CampyGen system for
broth cultures. Growth media were supplemented with chloram-
phenicol (Cm; 20 mg/mL) or kanamycin (Km; 50 mg/mL), where
appropriate. E. coli strains used for plasmid construction were
grown at 37uC in Luria-Bertani (LB; Sigma) broth or 7.5% agar
(w/v) and supplemented with ampicillin (100 mg/mL), Cm
(15 mg/mL), or Km (25 mg/mL), as necessary.
RNA extraction, cDNA synthesis and RT-qPCR
RNA was extracted from log phase broth bacteria (OD 0.3), and
cDNA was generated from the RNA, as described previously
[74,76]. The expression ratio of pgp1 was determined relative to
the C. jejuni gyrA gene encoding DNA gyrase subunit A. The
primer and TaqMan probe sequences used for qPCR are
described in Text S1. Each qPCR reaction mixture consisted of
25 ng of cDNA, 950 nM of each primer, 250 nM TaqMan probe,
and 10 ml 26 TaqMan Gene Expression Master Mix (Applied
Biosystems) in a total volume of 20 ml. Duplicate reactions for the
gene of interest and the housekeeping gene were run in a
Stratagene Mx3000P real-time PCR system for 2 min at 60uC,
10 min at 95uC, and then 40 cycles of 15 s at 95uC and 1 min at
60uC. The quantitative PCR cycle threshold (CT) results were
analyzed by the comparative CT method (DDCT method).
Calcofluor white (CFW) mutant screen
The C. jejni 81-176::solo(KmR) and C. jejuni 81-176::picard(CmR)
Tn libraries (Tn library construction is described in Text S1) and
were screened on CFW, as described previously [10].
Microscopy
Transmission electron microscopy (TEM) was carried out on 18 h
broth cultures. Samples were fixed in a final concentration of 2.5%
(v/v) of gluteraldehyde for 2–3 h on ice. Cells were then harvested,
resuspended in an equal volume of H2O, and stored at 4uC. For
imaging, 2 mL of bacteria was spotted onto parafilm to which 4 mL of
0.5% uranyl acetate was added for 1 min. A formavar-carbon film
on 300 mesh copper grid (Canemco, Lakefield, Quebec, Canada)
was added to the bacteria-uranyl acetate spot for 2 min. The grid
was then removed, dried, washed ten times in sterile water, dried
again and visualized on a Hitachi H7600 TEM equipped with a side
mount AMT Advantage (1 mega-pixel) CCD camera (Hamamatsu
ORCA) at the UBC Bioimaging facility (The University of British
Columbia, Vancouver, BC, Canada).
Phenotypic characterization: CFW, motility, and biofilm
formation
Phenotypic assays were carried out with strains grown in
shaking MH-TV broth or biphasic cultures grown for 18 h. CFW
fluorescence was assayed as described previously [10]. For
motility, cultures were diluted to an OD600 of 0.2 in MH-TV
and 2 ml was point inoculated into MH-TV plates containing
0.4% agar. Plates were incubated for 20 h and the halo diameter
was measured. Biofilm formation was assayed using crystal violet
as described previously [11] with the exception that the
absorbance was measured at 570 nm.
Peptidoglycan isolation and muropeptide analysis
C. jejuni strains were passaged once from frozen stocks and then
passaged to 20–25 MH plates and grown for 20 h to obtain log-
phase bacteria at a final OD of 200–600. Cells were collected into
cold MH broth by scraping, harvested by centrifugation at 8 0006
g for 15 min and then resuspended in 6 mL ice cold H2O. Cells
were lysed by dropwise addition to 6 mL 8% SDS boiling under
reflux. PG was purified from the cell lysate, digested with the
muramidase cellosyl (kindly provided by Hoechst, Frankfurt,
Germany), and the resulting muropeptides were reduced with
sodium borohydride and separated by HPLC as described [77].
Muropeptide fractions were collected, concentrated in a Speed-
Vac, acidified by 1% trifluoroacetic acid, and analysed by offline
electrospray mass spectrometry on a Finnigan LTQ-FT mass
spectrometer (ThermoElectron, Bremen, Germany) at the New-
castle University Pinnacle facility as described [25]. Muropeptide
structures were assigned based on (i) comparison with retention
times of known muropeptides from H. pylori, Caulobacter crescentus
and E. coli and (ii) the obtained MS data (Table S3) and MS/MS
fragmentation patterns (not shown).
Expression, purification and enzymatic activity of Pgp1
The C. jejuni 81-176 pgp1 gene was cloned for expression in E. coli
without its signal peptide (amino acids 16–464 of the protein) in
frame with the thioredoxin- and His-tag of the pET32a vector to
give plasmid pEF46. A detailed description of the cloning of the
expression construct, and the expression and purification protocol is
included in Text S1. For enzyme assays, the purified protein was
dialysed against 0.05 M Tris-Cl, pH 7.5 containing 0.01 M ZnCl2,
0.3 M NaCl and 20% glycerol. Purified Dpgp1 PG (1.0 mg/ml) was
incubated with Trx-His6-Pgp1 (5 mM) in 0.02 M NaH2PO4,
pH 4.8, 0.005 M ZnCl2, and 0.1 M NaCl for 4 h at 37uC on a
Thermomixer at 750 rpm. A control sample received no enzyme
and another enzyme sample contained 0.01 M EDTA and no
ZnCl2. The samples were incubated with 10 mg of cellosyl (Hoechst,
Frankfurt am Main, Germany) for 1 h, boiled for 10 min and
centrifuged at room temperature for 15 min at 16 000 g. The
muropeptides present in the supernatant were reduced with sodium
borohydride and analyzed by HPLC, as described [24].
Chick colonization
Chick colonization was performed as described previously
[61,76], with an infective dose of 104 CFU. Chicken experiments
were carried out under protocol #10462 approved by the
University of Michigan Committee on Care and Use of Animals
(UCUCA).
In vitro invasion and intracellular survival in epithelial and
macrophage cell lines
The human epithelial cell lines T84, Caco-2 and INT407 and
the murine RAW 264.7 and human Thp-1 macrophage cell lines
were used for C. jejuni infections. Carboxymethylcellulose (CMC)
was added to the tissue culture media to increase viscosity. A
detailed description of the tissue culture infections is included in
Text S1.
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Epithelial cell responses & Nod activation assays
Luciferase asssays were performed as previously described [46].
Briefly, HEK293T cells were transfected overnight with 75 ng of
NF-kB luciferase reporter plasmid (Igk-luc, Invitrogen) and either
human Nod1 (hNod1, 3 ng), mouse Nod1 (mNod1, 0.1 ng), or
human Nod2 (hNod2, 0.1 ng). The empty vector (pcDNA3.1,
Invitrogen) was used to balance the transfected DNA concentra-
tion. At the same time, either C. jejuni 81-176 or Dpgp1 PG
muropeptides at 0.1 mg/mL were added, and the NF-kB-
dependent luciferase activation was then measured following 18–
24 h of co-incubation. Positive controls were TriDAP (tripeptide
L-Ala-c-D-Glu-meso-DAP, 5 mg/ml), FK565 (a synthetic immuno-
stimulant tetrapeptide, heptanoyl-D-glutamyl-meso-DAP-D-alanine,
5 ug/ml), and MDP (muramyldipeptide, 10 mg/ml) for hNod1,
mNod1, and Nod2 assays, respectively. Data are representative of
three independent experiments.
Interleukin-8 quantification
The INT407 human epithelial cell line was seeded at
approximately 16105 cells/ml in MEM supplemented with 10%
FBS into 24-well tissue culture plates and allowed to grow for 20–
24 h prior to infection. The cells were washed three times with
MEM and either left uninfected or infected with either C. jejuni
wild-type strain 81-176 or Dpgp1 at an O.D.600 of 0.002/mL taken
from an 18 h shaking broth culture. Supernatants were collected
after 8 h and 24 h, centrifuged for 10 min to pellet residual cells
and bacteria, and frozen at 280uC until assayed. The concentra-
tion of IL-8 present in the supernatants was measured by the
human IL-8 ELISA kit (Invitrogen, Camarillo, CA).
Supporting Information
Figure S1 C. jejuni DcarB has a motility defect, but is
unaffected for chick colonization. A, negatively stained
TEM images of DcarB showing the full-length flagella and helical
morphology. B, DcarB exhibits a slight motility defect, as assayed
by measuring halo diameters in soft agar plates. Standard error of
the mean was calculated from 8 measurements. The asterisks (***)
indicate a statistically significant difference (p,0.001) using the
unpaired Student’s t-test. C, DcarB shows no defect for chick
colonization. Each point represents the log CFU/g cecal contents
of an individual chick 6 days following infection with 104 CFUs of
the indicated C. jejuni strains. The geometric mean is denoted by a
black bar.
(TIF)
Figure S2 C. jejuni Dpgp1 shows slightly enhanced
intracellular survival, but no defect in invasion in the
presence of carboxymethylcellulose (CMC). A, a gentami-
cin (Gm) protection assay was used to assess the invasion and
intracellular survival ability of Dpgp1 in Caco-2 intestinal epithelial
cells. Gm was added 3 h post-infection with bacterial strains. After
2 h the Gm was washed off and the cells were incubated with fresh
MEM containing 3% FBS and a low dose of Gm. B, infections
were carried out in the presence of MEM containing 1% and 2%
CMC to examine the ability of Dpgp1 to invade INT407 epithelial
cells in higher viscosity media. CFUs were determined for each
well by lysing the cells with water and plating the dilutions onto
MH-TV plates. Standard errors of the mean were calculated from
triplicate readings and are representative of three independent
experiments. The asterisk (*) indicates a statistically significant
difference (p,0.05) using the unpaired Student’s t-test.
(TIF)
Table S1 BLAST results for the C. jejuni 81-176 1344/
pgp1 gene product.
(DOC)
Table S2 Summary of Dpgp1 phenotypes tested that
were similar to wild type.
(DOC)
Table S3 Molecular mass of C. jejuni 81-176 muropep-
tides (reduced form) separated by HPLC and analyzed
by LTQ-FT-MS.
(DOC)
Table S4 Muropeptide compositional analysis used to
determine the values in Table 1.
(DOC)
Table S5 PGmuropeptide composition of C. jejuni wild-
type strain 81-176 in comparison to H. pylori and E. coli.
(DOC)
Text S1 Supplemental materials and methods.
(DOC)
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